PSX
29
4
UAL
77
5
AEP
56
5
MKC
53
2
MOS
48
-2
ADM
22
-2
SE
65
5
TGNA
48
-2
CLX
68
2
AMT
28
3
V
50
2
AKAM
37
3
NI
65
9
EXPD
23
2
HCA
48
6
ETN
69
2
MDT
64
8
SIG
38
-3
GOOGL
54
-4
BAC
56
2
PSX
29
4
UAL
77
5
AEP
56
5
MKC
53
2
MOS
48
-2
ADM
22
-2
SE
65
5
TGNA
48
-2
CLX
68
2
AMT
28
3
V
50
2
AKAM
37
3
NI
65
9
EXPD
23
2
HCA
48
6
ETN
69
2
MDT
64
8
SIG
38
-3
GOOGL
54
-4
BAC
56
2
Financhill
Back

PTC Therapeutics Vs. Nukkleus Industry Stock Comparison

Sell
34

PTCT
PTC Therapeutics

Last Price:
$43.98
Seasonality Move:
-1.85%
Sell
23

NUKK
Nukkleus

Last Price:
$19.61
Seasonality Move:
48.46%
Sell
34
PTC Therapeutics (PTCT) is a Sell

Is PTC Therapeutics a Buy, Sell or Hold?

  • The current PTC Therapeutics [PTCT] share price is $45.04. The Score for PTCT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • PTCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Nukkleus (NUKK) is a Sell

Is Nukkleus a Buy, Sell or Hold?

  • The current Nukkleus [NUKK] share price is $21.00. The Score for NUKK is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NUKK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PTCT Stock Price Chart

What is PTC Therapeutics's stock price today?

  • The PTC Therapeutics share price today is $45.04
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTCT is experiencing buying pressure, which is a positive indicator for future bullish movement.

NUKK Stock Price Chart

What is Nukkleus's stock price today?

  • The Nukkleus share price today is $21.00
    The current trend is moderately bearish and NUKK is experiencing slight selling pressure.

PTCT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 47.62 Sell
Chaikin Money Flow: 446895 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.13 - 48.59) Sell
Bollinger Bands (100): (35.04 - 45.64) Buy

NUKK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.09 Buy
Relative Strength Index (14 RSI): 48.74 Sell
Chaikin Money Flow: -90986 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.08 - 39.18) Sell
Bollinger Bands (100): (-5.25 - 19.13) Buy

PTCT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.5 Sell
20-day SMA: 46.34 Sell
50-day SMA: 44.78 Buy
200-day SMA: 36.29 Buy
8-day EMA: 45.49 Sell
20-day EMA: 45.79 Sell
50-day EMA: 44.35 Buy
200-day EMA: 38.13 Buy

NUKK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 30 Sell
20-day SMA: 26.02 Sell
50-day SMA: 11.64 Buy
200-day SMA: 6.16 Buy
8-day EMA: 27.7 Sell
20-day EMA: 25.09 Sell
50-day EMA: 16.11 Buy
200-day EMA: 13.92 Buy

PTC Therapeutics Earnings Growth & PTCT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and an increase next year of $1.05 per share.

Nukkleus Earnings Growth & NUKK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

PTC Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nukkleus Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):